DE69527777T2 - Antibiotisch wirksame stalobacine - Google Patents

Antibiotisch wirksame stalobacine

Info

Publication number
DE69527777T2
DE69527777T2 DE69527777T DE69527777T DE69527777T2 DE 69527777 T2 DE69527777 T2 DE 69527777T2 DE 69527777 T DE69527777 T DE 69527777T DE 69527777 T DE69527777 T DE 69527777T DE 69527777 T2 DE69527777 T2 DE 69527777T2
Authority
DE
Germany
Prior art keywords
stalobacin
antibiotic
pbj
deposit
pseudomonas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527777T
Other languages
German (de)
English (en)
Other versions
DE69527777D1 (de
Inventor
Bunji Kageyama
Susumu Kamata
Toshiyuki Kamigauchi
Yoshimi Kawamura
Koichi Matsumoto
Shigeru Matsutani
Shigeo Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE69527777D1 publication Critical patent/DE69527777D1/de
Publication of DE69527777T2 publication Critical patent/DE69527777T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/04—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69527777T 1994-03-01 1995-02-28 Antibiotisch wirksame stalobacine Expired - Fee Related DE69527777T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP03121994A JP3568978B2 (ja) 1994-03-01 1994-03-01 抗生物質スタロバシン類
PCT/JP1995/000314 WO1995023812A1 (en) 1994-03-01 1995-02-28 Antibiotic stalobacins

Publications (2)

Publication Number Publication Date
DE69527777D1 DE69527777D1 (de) 2002-09-19
DE69527777T2 true DE69527777T2 (de) 2003-04-10

Family

ID=12325329

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527777T Expired - Fee Related DE69527777T2 (de) 1994-03-01 1995-02-28 Antibiotisch wirksame stalobacine

Country Status (11)

Country Link
EP (1) EP0748335B1 (enExample)
JP (1) JP3568978B2 (enExample)
KR (1) KR100349771B1 (enExample)
CN (1) CN1065538C (enExample)
AT (1) ATE222262T1 (enExample)
CA (1) CA2183951A1 (enExample)
DE (1) DE69527777T2 (enExample)
ES (1) ES2181768T3 (enExample)
MX (1) MX9603613A (enExample)
TW (1) TW318853B (enExample)
WO (1) WO1995023812A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0230496A (ja) * 1988-07-18 1990-01-31 Tokai Rubber Ind Ltd ゴムの加湿切断方法及び装置
JP2614920B2 (ja) * 1989-05-18 1997-05-28 塩野義製薬株式会社 抗生物質ｐｂｊ―５，３６０複合体
AU669187B2 (en) * 1992-08-25 1996-05-30 Shionogi & Co., Ltd. Antibiotic stalobacins

Also Published As

Publication number Publication date
WO1995023812A1 (en) 1995-09-08
TW318853B (enExample) 1997-11-01
JPH07242686A (ja) 1995-09-19
ES2181768T3 (es) 2003-03-01
KR100349771B1 (ko) 2002-12-11
KR970701205A (ko) 1997-03-17
CN1142230A (zh) 1997-02-05
MX9603613A (es) 1997-06-28
CN1065538C (zh) 2001-05-09
EP0748335B1 (en) 2002-08-14
CA2183951A1 (en) 1995-09-08
JP3568978B2 (ja) 2004-09-22
EP0748335A1 (en) 1996-12-18
DE69527777D1 (de) 2002-09-19
ATE222262T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
DE60006690T2 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
DE69735099T2 (de) Antibiotika rk-1061 und verfahren zu ihrer herstellung
DE69008795T2 (de) Trehalostatin und seine herstellung.
DE69604385T2 (de) Isocumarine mit antitumorwirkung
DE3332593A1 (de) Neues antibiotikum und verfahren zu dessen herstellung
US4843008A (en) Novel microorganisms and a novel process for producing antibiotics
DE69218067T2 (de) Verfahren zur Herstellung von 3-deacylierten Derivaten eines 16-gliedrigen Macrolid-Antibiotikums, hierfür verwendeter Mikroorganismus, sowie neues Macrolid-Antibiotikum
US5171836A (en) Antibiotics plusbacin
DE3782199T2 (de) Biologisch aktive peptide tan-866.
US4940582A (en) Antibiotic YI-HU3
DE3687016T2 (de) Antibiotika tan-749, deren herstellung und anwendung.
JP3568978B2 (ja) 抗生物質スタロバシン類
EP0891376B1 (de) Antifungische peptide aus scleroderma texense
DE3881812T2 (de) Physiologisch aktive Substanzen, Probestin und Prostatin und deren Herstellung.
JP2614920B2 (ja) 抗生物質ｐｂｊ―５，３６０複合体
JP3542150B2 (ja) 抗生物質スタロバシン
DE3687189T2 (de) Antitumor- und antimikroben-verbindung, deren mikrobiologische herstellung und deren benutzung als arzneimittel.
DE69011952T2 (de) Physiologisch aktive Verbindungen SN-198C sowie Verfahren und Bakterien zu deren Herstellung.
GB1597662A (en) Copper-containing peptide antibiotic
AT388385B (de) Neue antibiotika, ein mikrobiologisches verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3407979A1 (de) Spicamycin sowie verfahren zu seiner herstellung
US5456910A (en) Antibiotic stalobacins
US6103231A (en) Antibiotic stalobacins
DE69000335T2 (de) Butalactin, verfahren zu seiner herstellung und seine verwendung als arzneimittel.
DE69023804T2 (de) DC115A-Verbindungen mit antibakterieller und antitumor Wirkung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee